Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$157747.0.

  • HCW Biologics' Other Working Capital Changes fell 2595.78% to -$157747.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$165482.0, marking a year-over-year increase of 8905.88%. This contributed to the annual value of $9928.0 for FY2024, which is 14132.23% up from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Other Working Capital Changes is -$157747.0, which was down 2595.78% from -$263050.0 recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Other Working Capital Changes registered a high of $1.6 million during Q3 2021, and its lowest value of -$1.4 million during Q1 2022.
  • For the 5-year period, HCW Biologics' Other Working Capital Changes averaged around -$58439.1, with its median value being -$150356.0 (2021).
  • As far as peak fluctuations go, HCW Biologics' Other Working Capital Changes soared by 418465.22% in 2023, and later crashed by 193986.88% in 2024.
  • Over the past 5 years, HCW Biologics' Other Working Capital Changes (Quarter) stood at $617923.0 in 2021, then tumbled by 201.74% to -$628667.0 in 2022, then dropped by 8.71% to -$683418.0 in 2023, then soared by 99.62% to -$2579.0 in 2024, then plummeted by 6016.6% to -$157747.0 in 2025.
  • Its Other Working Capital Changes stands at -$157747.0 for Q3 2025, versus -$263050.0 for Q2 2025 and $257894.0 for Q1 2025.